CN103007059B - 一种治疗偏头痛的中药组合物及制备方法 - Google Patents
一种治疗偏头痛的中药组合物及制备方法 Download PDFInfo
- Publication number
- CN103007059B CN103007059B CN201210406324.6A CN201210406324A CN103007059B CN 103007059 B CN103007059 B CN 103007059B CN 201210406324 A CN201210406324 A CN 201210406324A CN 103007059 B CN103007059 B CN 103007059B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 208000019695 Migraine disease Diseases 0.000 title abstract description 36
- 206010027599 migraine Diseases 0.000 title abstract description 35
- 241000522620 Scorpio Species 0.000 claims abstract description 13
- 241001643642 Viticis Species 0.000 claims abstract description 13
- 239000009490 scorpio Substances 0.000 claims abstract description 13
- 241000746716 Typhonium Species 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 14
- 239000006187 pill Substances 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 13
- 241000131808 Scolopendra Species 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 241000237903 Hirudo Species 0.000 claims description 12
- 241000972155 Moschus Species 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 208000002193 Pain Diseases 0.000 abstract description 43
- 230000036407 pain Effects 0.000 abstract description 40
- 239000008280 blood Substances 0.000 abstract description 36
- 210000004185 liver Anatomy 0.000 abstract description 36
- 210000004369 blood Anatomy 0.000 abstract description 34
- 206010019233 Headaches Diseases 0.000 abstract description 24
- 231100000869 headache Toxicity 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 10
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000205754 Colocasia esculenta Species 0.000 abstract 1
- 235000006481 Colocasia esculenta Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 208000004371 toothache Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 230000001154 acute effect Effects 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000001431 Psychomotor Agitation Diseases 0.000 description 5
- 206010038743 Restlessness Diseases 0.000 description 5
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 5
- 229960000623 carbamazepine Drugs 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 238000002636 symptomatic treatment Methods 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 230000003447 ipsilateral effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- -1 each 1000 μ g Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010063006 Facial spasm Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 229960002297 fenofibrate Drugs 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Abstract
Description
组别(例) | 男/女(例) | 年龄(岁) | 紧张性偏头痛(例) | 三叉神经性偏头痛(例) | 血管性偏头痛(例) | 颈椎性偏头痛(例) | 经前性偏头痛(例) |
治疗组83 | 28/55 | 39.6 | 21 | 18 | 19 | 12 | 13 |
对照组83 | 25/58 | 38 | 20 | 19 | 18 | 15 | 11 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210406324.6A CN103007059B (zh) | 2012-10-23 | 2012-10-23 | 一种治疗偏头痛的中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210406324.6A CN103007059B (zh) | 2012-10-23 | 2012-10-23 | 一种治疗偏头痛的中药组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103007059A CN103007059A (zh) | 2013-04-03 |
CN103007059B true CN103007059B (zh) | 2015-02-25 |
Family
ID=47956522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210406324.6A Active CN103007059B (zh) | 2012-10-23 | 2012-10-23 | 一种治疗偏头痛的中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103007059B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599403B (zh) * | 2013-12-02 | 2015-07-22 | 咸温东 | 一种治疗偏头痛的中药组合物及其制备方法 |
CN104758346A (zh) * | 2015-04-23 | 2015-07-08 | 邵勇 | 一种治疗偏头痛的药物及其制备方法、制剂 |
CN105232791A (zh) * | 2015-11-11 | 2016-01-13 | 吴川杰 | 一种神经内科治疗偏头疼的中药 |
CN105381084A (zh) * | 2015-12-23 | 2016-03-09 | 刘可 | 一种治疗偏头痛的中药组合物及其制备方法和用途 |
CN107441360A (zh) * | 2017-08-15 | 2017-12-08 | 广西民族大学 | 一种治疗偏头痛的太阳穴贴剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575810A (zh) * | 2003-07-28 | 2005-02-09 | 陈文华 | 一种治疗顽固性头痛的中药 |
-
2012
- 2012-10-23 CN CN201210406324.6A patent/CN103007059B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1575810A (zh) * | 2003-07-28 | 2005-02-09 | 陈文华 | 一种治疗顽固性头痛的中药 |
Non-Patent Citations (1)
Title |
---|
中药治疗偏头痛处方规律分析及脑痛立停胶囊治疗偏头痛作用机理研究;王玲玲;《北京中医药大学博士研究生学位论文》;20071231;34-36 * |
Also Published As
Publication number | Publication date |
---|---|
CN103007059A (zh) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263488B (zh) | 治疗卡培他滨致手足综合征的中药熏洗汤剂 | |
CN103007059B (zh) | 一种治疗偏头痛的中药组合物及制备方法 | |
CN102274385B (zh) | 一种治疗鼻窦炎的药物及其制备方法 | |
CN103251709A (zh) | 一种用于制备治疗鼻炎外用药物的鼻通膏及其制备方法 | |
CN102988645A (zh) | 一种治疗面神经麻痹的中药组合物及制备方法 | |
CN103550698B (zh) | 一种治疗急性胆囊炎的中药组合物 | |
CN102614331B (zh) | 治疗耳鸣耳聋的中药制剂 | |
CN104116971A (zh) | 一种治疗肝病瘙痒的中药组合物及其制备方法 | |
CN1970040A (zh) | 治疗由动脉粥样硬化引起的高血压、糖尿病和冠心病的中药 | |
CN102327498A (zh) | 含有紫杉醇浸膏的抗癌新药 | |
CN105878454A (zh) | 用于治疗中风偏瘫和风湿痹痛的药物组合物及其制备方法 | |
CN101502597B (zh) | 一种用于治疗胃痛的药物及其制备方法 | |
CN101804108A (zh) | 一种治疗神经性头痛的中药组合物 | |
CN104055925A (zh) | 一种治疗糖尿病周围神经病变的中药组合物 | |
CN103893675A (zh) | 一种治疗胃脘痛中药制剂 | |
CN103120789A (zh) | 一种治疗偏头痛的中药组合物 | |
CN103751437B (zh) | 一种治疗原发性痛经的中药组合物 | |
CN102836241A (zh) | 治疗脊柱退行性改变引起的颈肩腰腿疼痛的中药组合物 | |
CN107029055A (zh) | 用于治疗肝热血瘀所致白血病的中药复方制剂及制备方法 | |
CN104784358A (zh) | 一种治疗偏头痛的中药 | |
CN100363024C (zh) | 一种治疗糖尿病周围神经病变的中药-麻痛消 | |
CN101229255A (zh) | 一种治疗急性腰部损伤的纯中药配方 | |
CN105412625A (zh) | 一种用于治疗内伤头痛的中药组合物 | |
CN101804187B (zh) | 一种治疗慢性缺血性脑血管病的中药组合物 | |
CN104524090A (zh) | 一种治疗头部损伤后遗症的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201130 Address after: 224000 building 202, building 57, shuanglongxing village, Hede Town, Sheyang County, Yancheng City, Jiangsu Province Patentee after: Chen Guoquan Address before: Puyang City, Henan province 457400 old Cross Street South 150 meters southwest of Le Nanle county county hospital Patentee before: Pan Genqi |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231027 Address after: No. 1 Minsheng Road, Daishi Town, Qianfeng District, Guang'an City, Sichuan Province, 638500 Patentee after: Wei Chunjiang Address before: 224000 building 202, building 57, shuanglongxing village, Hede Town, Sheyang County, Yancheng City, Jiangsu Province Patentee before: Chen Guoquan |